French functional proteomics company Hybrigenics has developed a novelcomputational approach for predicting cellular protein interactions across a whole organism, which is said to deliver substantial advantages in sensitivity and accuracy over current predictive methods. The Interaction-Domain Pair Profile method, published in Bioinformatics (17, sup 1), allows researchers to predict, with great precision, the interaction map of a target organism based on the analysis of a similar high-quality map determined experimentally.
Hybrigenics has applied this proprietary approach to build a bacterial protein interaction map of Escherichia coli from its biochemical data on Helicobacter pylori. The methodology is currently being developed for application in mammalian cells.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze